Esperion Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of ESPR for the last quarter is 137.74 M USD, and it's 327.09% higher compared to the previous quarter. The net income of Q1 24 is 61.02 M USD.